# Atlas Usage Impact Review 001

Objective: determine whether Atlas V1 Research Evidence Librarian and Research Synthesis changed or improved any real AEGIS research conclusion from tonight's Research Journal work.

Scope: existing Research Journal reports and read-only Atlas CLI outputs only. This review does not add schemas, mechanisms, registries, runtime truth changes, candidate logic, sleeve behavior, trading logic, capital allocation, or new Atlas capabilities.

Evidence used:
- `research_journal/reports/journal_review_002.md`
- `research_journal/reports/root_cause_review_001.md`
- `research_journal/reports/outcome_maturity_acceleration_review_001.md`
- `research_journal/reports/atlas_v1_prioritization_review_001.md`
- `research_journal/reports/atlas_v1_build_plan_001.md`
- Evidence Librarian outputs for `outcome maturity` and `candidate volume`
- Research Synthesis outputs for `outcome maturity`, `candidate volume`, `capital review readiness`, `technical strategy evidence`, and `evidence concentration`

## Atlas capability value

Atlas reached the same major conclusions as the manual reviews for the queries it supported.

For `outcome maturity`, the Evidence Librarian retrieved `OBS_0002`, `KNW_0006`, `KNW_0017`, `FAIL_0004`, `journal_review_002.md`, `root_cause_review_001.md`, `outcome_maturity_acceleration_review_001.md`, `c2_trend_eq_outcome_review_001.md`, and related outcome-flow reports. Research Synthesis compressed those into the same diagnosis found manually: closed, usable, distributed outcomes remain underpowered; paper-position volume and architecture readiness do not equal mature evidence; and `C2_TREND_EQ_PRIMARY_V1` is the main usable evidence stream without being proven capital-ready or positive.

For `candidate volume`, Atlas retrieved `OBS_0007`, `OBS_0017`, `FAIL_0007`, `journal_review_002.md`, `root_cause_review_001.md`, `outcome_maturity_acceleration_review_001.md`, and related candidate-funnel reports. It matched the manual conclusion that raw signal or candidate volume is not a candidate-quality proxy because conversion, certification, portfolio suppression, paper-path, and validation blockers must be separated.

For `capital review readiness`, Research Synthesis retrieved `OBS_0010`, `OBS_0013`, `weekly_learning_report.md`, and the major review reports. It matched the manual conclusion that research attention and evidence follow-through are currently more useful than capital review because evidence remains underpowered and capital-review readiness is not established.

For `technical strategy evidence`, Research Synthesis retrieved `OBS_0003`, `KNW_0008`, `KNW_0018`, and `FAIL_0016`. It matched the manual conclusion that standalone technical-indicator claims remained weak and that technical evidence should be relationship-specific, mechanism-linked, context-linked, or out-of-fixture tested.

For `evidence concentration`, Research Synthesis retrieved `c2_trend_eq_outcome_review_001.md`, `c2_trend_eq_open_outcome_flow_review_001.md`, `outcome_maturity_acceleration_review_001.md`, and `evidence_accumulation_forecast_review_001.md`. It matched the manual conclusion that evidence is concentrated in `C2_TREND_EQ_PRIMARY_V1`, that this makes it the easiest evidence stream, and that concentration remains a limitation.

Atlas did not materially change any diagnosis. Its value was retrieval coverage and compression. It reduced effort by gathering relevant OBS, KNW, FAIL, and report paths quickly, then grouping retrieved lines into support, limiting evidence, open questions, and source paths. The most useful improvement was preventing a reviewer from manually re-searching the same repeated evidence threads.

Atlas also surfaced some adjacent evidence that a narrow manual review could overlook, especially cross-links among `decision_risk_monitor_001.md`, `fragile_conclusion_review_001.md`, `outcome_bottleneck_decomposition_review_001.md`, and the Atlas roadmap/build-plan reports. These did not change conclusions, but they made the reuse trail clearer.

Limitations: Atlas output is keyword-bound and snippet-bound. It can include scope or non-goal boilerplate in limiting/open-question sections because those lines contain terms such as `not`, `no`, `blocked`, or `underpowered`. This is conservative and citation-bound, but noisy. Atlas also cannot yet judge whether it missed evidence outside the retrieved keyword surface unless a human compares the result to known source sets.

## Human review value

Human review still provided the strongest value where judgment, scope control, and source reconciliation were required.

Manual reviews ranked root causes by evidence strength, distinguished primary bottlenecks from downstream symptoms, and separated actionability from observability. Root Cause Review 001 concluded that paper trades were not compelling research candidates primarily because outcome and validation samples remained underpowered, with candidate conversion, evidence concentration, implementation/data repair, and weak early realized performance as supporting causes. Atlas retrieved and compressed evidence for these themes, but it did not independently rank root causes.

Manual reviews also resolved ambiguity that Atlas only surfaced. Outcome Maturity Acceleration Review 001 distinguished fast outcome accumulation from capital readiness, warned against forcing closure, and identified paper-active zero-sample sleeves as distribution-improving targets. Atlas could retrieve those statements, but it did not independently decide which next action was safest or highest leverage.

Human review was necessary to decide whether Atlas missed important evidence. Atlas did not explicitly know the full intended evidence set for each question. It found the main journal/report surfaces, but human comparison was needed to confirm that the major manual conclusions were represented and that missing items did not alter the result.

Human review also preserved the frozen-phase boundary. Atlas output repeatedly included non-authoritative boundary language, but humans still had to decide not to create new objects, not to expand architecture, not to modify runtime truth, and not to interpret retrieved statements as validation authority.

## Combined workflow value

The combined workflow is stronger than either manual review or Atlas alone.

A practical review flow is:
1. Use Evidence Librarian to retrieve candidate source paths and snippets.
2. Use Research Synthesis to compress retrieved evidence into support, limitations, and open questions.
3. Use human review to check coverage, remove boilerplate noise, reconcile source conflicts, and decide whether the conclusion should remain unchanged, be narrowed, or require a targeted evidence check.

Using Atlas first would have reduced review effort for tonight's major findings. The `outcome maturity`, `candidate volume`, `technical strategy evidence`, `capital review readiness`, and `evidence concentration` outputs all reached the same broad conclusion surfaces as the manual reports. Atlas alone would have been enough to identify likely evidence clusters and avoid many manual searches.

Atlas alone would not have been enough to produce the full manual findings. It did not establish root-cause ranking, did not distinguish primary causes from visible symptoms with the same rigor, did not determine whether evidence gaps required a split or new follow-through review, and did not decide whether a conclusion was fragile enough to monitor.

Atlas changed the process more than it changed the conclusions. The major findings would still have required human synthesis, but Atlas would have made them faster to assemble and easier to cite. The clearest value is not automated research judgment; it is disciplined retrieval and compression before human judgment.

Answer to the core impact questions:
- Did Atlas reach the same conclusions? Yes, for supported query areas.
- Did Atlas miss important evidence? No major conclusion-changing miss was observed, but coverage still depends on query phrasing and human comparison.
- Did Atlas surface evidence humans overlooked? It surfaced adjacent report links and reuse trails, but no diagnosis-changing overlooked evidence.
- Did Atlas reduce review effort? Yes. It reduced repeated search and source-path collection.
- Did Atlas change any diagnosis? No.
- Would tonight's major findings have been possible using Atlas alone? Partially. Atlas could identify and cite the main evidence clusters, but human review was still required for ranking, diagnosis, scope control, and final interpretation.

## Most important missing Atlas capability

The most important missing Atlas capability is Negative Knowledge / Failure Reuse.

Reason: tonight's conclusions repeatedly depended on prior failed assumptions: architecture maturity did not imply evidence maturity, paper workflow progress did not imply live readiness, candidate volume did not imply candidate quality, standalone technical-indicator evidence did not support durable broad claims, and capital review was premature while evidence remained underpowered.

The Evidence Librarian can retrieve failures when the query overlaps their text. Research Synthesis can place failure snippets into limiting evidence. But neither capability is explicitly designed to start from prior failures, corrected misdiagnoses, and do-not-repeat cautions before a new review begins.

A read-only Negative Knowledge / Failure Reuse CLI would improve the combined workflow by making every new review ask: what have we already been wrong about on this topic? It should remain advisory, citation-bound, deterministic, and non-authoritative. It must not veto research, mark hypotheses invalid, change journal status, validate claims, recommend trades, allocate capital, or create new objects.
